[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB9719189D0 - New therapeutic method - Google Patents

New therapeutic method

Info

Publication number
GB9719189D0
GB9719189D0 GBGB9719189.4A GB9719189A GB9719189D0 GB 9719189 D0 GB9719189 D0 GB 9719189D0 GB 9719189 A GB9719189 A GB 9719189A GB 9719189 D0 GB9719189 D0 GB 9719189D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic method
new therapeutic
new
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9719189.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB9719189.4A priority Critical patent/GB9719189D0/en
Publication of GB9719189D0 publication Critical patent/GB9719189D0/en
Priority to JP10541320A priority patent/JP2000513013A/en
Priority to EP98914960A priority patent/EP0973775A1/en
Priority to CA002286367A priority patent/CA2286367A1/en
Priority to AU69261/98A priority patent/AU6926198A/en
Priority to PCT/GB1998/000982 priority patent/WO1998043975A1/en
Priority to PE1998000828A priority patent/PE107899A1/en
Priority to CA002303176A priority patent/CA2303176A1/en
Priority to PCT/EP1998/005609 priority patent/WO1999012933A2/en
Priority to CN98810954A priority patent/CN1278820A/en
Priority to PCT/EP1998/005607 priority patent/WO1999012932A1/en
Priority to SK319-2000A priority patent/SK3192000A3/en
Priority to IDW20000445A priority patent/ID24452A/en
Priority to ZA9808160A priority patent/ZA988160B/en
Priority to HU0004644A priority patent/HUP0004644A3/en
Priority to AU97412/98A priority patent/AU9741298A/en
Priority to EEP200000138A priority patent/EE200000138A/en
Priority to EP98951348A priority patent/EP1003748A2/en
Priority to AU95362/98A priority patent/AU9536298A/en
Priority to NZ503130A priority patent/NZ503130A/en
Priority to PL98339176A priority patent/PL339176A1/en
Priority to MA25243A priority patent/MA26543A1/en
Priority to IL13479198A priority patent/IL134791A0/en
Priority to JP2000510740A priority patent/JP2001515904A/en
Priority to EP98948907A priority patent/EP1015454A1/en
Priority to EA200000204A priority patent/EA200000204A1/en
Priority to TR2000/00907T priority patent/TR200000907T2/en
Priority to APAP/P/2000/001761A priority patent/AP2000001761A0/en
Priority to JP2000510739A priority patent/JP2001515903A/en
Priority to BR9812062-0A priority patent/BR9812062A/en
Priority to ARP980104458A priority patent/AR017072A1/en
Priority to KR1020007002422A priority patent/KR20010023766A/en
Priority to CO98051488A priority patent/CO4970719A1/en
Priority to IS5391A priority patent/IS5391A/en
Priority to NO20001198A priority patent/NO20001198L/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
GBGB9719189.4A 1997-04-02 1997-09-09 New therapeutic method Ceased GB9719189D0 (en)

Priority Applications (35)

Application Number Priority Date Filing Date Title
GBGB9719189.4A GB9719189D0 (en) 1997-09-09 1997-09-09 New therapeutic method
JP10541320A JP2000513013A (en) 1997-04-02 1998-04-02 Pyrrolopyrrolones derivatives
EP98914960A EP0973775A1 (en) 1997-04-02 1998-04-02 Pyrolopyrrolone derivatives
CA002286367A CA2286367A1 (en) 1997-04-02 1998-04-02 Pyrolopyrrolone derivatives
AU69261/98A AU6926198A (en) 1997-04-02 1998-04-02 Pyrolopyrrolone derivatives
PCT/GB1998/000982 WO1998043975A1 (en) 1997-04-02 1998-04-02 Pyrolopyrrolone derivatives
PE1998000828A PE107899A1 (en) 1997-09-09 1998-09-04 PIRROLOPYROLONE DERIVATIVES AS LEUCOCITARY ELASTASE INHIBITORS
KR1020007002422A KR20010023766A (en) 1997-09-09 1998-09-07 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
EEP200000138A EE200000138A (en) 1997-09-09 1998-09-07 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
IL13479198A IL134791A0 (en) 1997-09-09 1998-09-07 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
CN98810954A CN1278820A (en) 1997-09-09 1998-09-07 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
PCT/EP1998/005607 WO1999012932A1 (en) 1997-09-09 1998-09-07 Method of inhibiting serine protease enzymes
SK319-2000A SK3192000A3 (en) 1997-09-09 1998-09-07 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
IDW20000445A ID24452A (en) 1997-09-09 1998-09-07 PIRROLOPIRROLON DERIVITY AS A NEUTROFIL ELASTASE OBJECTIVE
ZA9808160A ZA988160B (en) 1997-09-09 1998-09-07 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
HU0004644A HUP0004644A3 (en) 1997-09-09 1998-09-07 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase and pharmaceutical compositions containing them
AU97412/98A AU9741298A (en) 1997-09-09 1998-09-07 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
CA002303176A CA2303176A1 (en) 1997-09-09 1998-09-07 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
EP98951348A EP1003748A2 (en) 1997-09-09 1998-09-07 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
AU95362/98A AU9536298A (en) 1997-09-09 1998-09-07 Method of inhibiting serine protease enzymes
NZ503130A NZ503130A (en) 1997-09-09 1998-09-07 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
PL98339176A PL339176A1 (en) 1997-09-09 1998-09-07 Derivatives of pyrrolopyrrolone as inhibitors of neutrophilic elastase
MA25243A MA26543A1 (en) 1997-09-09 1998-09-07 PYRROLOPYRROLONE DERIVATIVES AS NEUTROPHILIC ELASTASE INHIBITORS.
PCT/EP1998/005609 WO1999012933A2 (en) 1997-09-09 1998-09-07 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
JP2000510740A JP2001515904A (en) 1997-09-09 1998-09-07 Pyrrolopyrrolones as neutrophil elastase
EP98948907A EP1015454A1 (en) 1997-09-09 1998-09-07 Method of inhibiting serine protease enzymes
EA200000204A EA200000204A1 (en) 1997-09-09 1998-09-07 Pyrrolopyrlonone derivatives as ELASTASIS INHIBITORS NEUTROPHILS
TR2000/00907T TR200000907T2 (en) 1997-09-09 1998-09-07 Pyrolopirolone derivatives as neutrophil elastase inhibitors.
APAP/P/2000/001761A AP2000001761A0 (en) 1997-09-09 1998-09-07 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
JP2000510739A JP2001515903A (en) 1997-09-09 1998-09-07 Methods for inhibiting serine protease enzymes
BR9812062-0A BR9812062A (en) 1997-09-09 1998-09-07 Compound, use of this, process for preparing it, purified single enantiomer, pharmaceutical composition, and, processes for the treatment of chronic bronchitis or chronic obstructive pulmonary disease in a human or animal individual, and for treatment of asthma in a human or animal individual
ARP980104458A AR017072A1 (en) 1997-09-09 1998-09-07 COMPOUNDS DERIVED FROM PIRROLOPIRROLONA AS INHIBITORS OF NEUTROPHYLICAL ELASTASE, USE OF SUCH COMPOUNDS, TREATMENT METHODS, PROCESSES OF PREPARATION AND USEFUL INTERMEDIARIES FOR THEIR PRODUCTION
CO98051488A CO4970719A1 (en) 1997-09-09 1998-09-08 PIRROLOPYROLONE DERIVATIVES AS LEUCOCITARY ELASTASE INHIBITORS
IS5391A IS5391A (en) 1997-09-09 2000-02-29 Pyrrolopyrrolone derivatives that inhibit the elastase neutralization
NO20001198A NO20001198L (en) 1997-09-09 2000-03-08 Pyrrolopyrrole subunits as inhibitors of neutrophil elastase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9719189.4A GB9719189D0 (en) 1997-09-09 1997-09-09 New therapeutic method

Publications (1)

Publication Number Publication Date
GB9719189D0 true GB9719189D0 (en) 1997-11-12

Family

ID=10818822

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9719189.4A Ceased GB9719189D0 (en) 1997-04-02 1997-09-09 New therapeutic method

Country Status (6)

Country Link
EP (1) EP1015454A1 (en)
JP (1) JP2001515903A (en)
AU (1) AU9536298A (en)
GB (1) GB9719189D0 (en)
WO (1) WO1999012932A1 (en)
ZA (1) ZA988160B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0110832D0 (en) * 2001-05-03 2001-06-27 Virogen Ltd Antiviral compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9211783D0 (en) * 1992-06-04 1992-07-15 Ici Plc Amide derivatives
WO1995003278A1 (en) * 1993-07-26 1995-02-02 Zaidan Hojin Biseibutsu Kagaku Kenkyukai Pyrrolidine derivative or pharmaceutically acceptable salt thereof
AP823A (en) * 1996-03-28 2000-04-25 Glaxo Group Ltd Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.

Also Published As

Publication number Publication date
ZA988160B (en) 2000-03-22
EP1015454A1 (en) 2000-07-05
JP2001515903A (en) 2001-09-25
AU9536298A (en) 1999-03-29
WO1999012932A1 (en) 1999-03-18

Similar Documents

Publication Publication Date Title
ZA982368B (en) New therapeutic combinations
HUP0000911A3 (en) Refuse-treatment method
GB2345063B (en) Method
GB9721603D0 (en) Method
GB9706282D0 (en) Method
GB9410320D0 (en) Novel therapeutic method
GB9700320D0 (en) Method
GB9700939D0 (en) Therapy
GB9719161D0 (en) New therapeutic method
ZA9810471B (en) New method
GB9707744D0 (en) Method
GB9717652D0 (en) Method
GB9714841D0 (en) Treatment method
PL341657A1 (en) Deparaffining method
GB9719176D0 (en) New therapeutic method
GB9719189D0 (en) New therapeutic method
GB9719166D0 (en) New therapeutic method
GB9719167D0 (en) New therapeutic method
GB9719163D0 (en) New therapeutic method
GB9709811D0 (en) Method
GB9800683D0 (en) Therapeutic method
GB9804285D0 (en) Therapeutic method
GB9414242D0 (en) Therapeutic method
GB9517851D0 (en) New therapeutic method
GB9703102D0 (en) Treatment method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)